Showing results (1421-1430 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 28, 2013
Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cellsA A Goldberg, V I Titorenko, A Beach, et al.
Investigational New Drugs|June 14, 2013
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trialCraig Reynolds, Alexander I Spira, Larry Gluck, et al.
Investigational New Drugs|May 1, 1990
In vivo and in vitro pharmacokinetics of 4,6-benzylidene-D-glucose (BG) in ratsJ M Dornish, R O Larsen, P E Schwarze, et al.
Investigational New Drugs|May 1, 1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group studyW P McGuire, J A Blessing, K D Hatch, et al.
Investigational New Drugs|March 26, 2013
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumorsShubham Pant, Howard A Burris, Kathleen Moore, et al.
Investigational New Drugs|March 26, 2013
Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancerKunio Okamoto, Isamu Okamoto, Masaki Miyazaki, et al.
Investigational New Drugs|August 29, 2013
Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancerPrasanth Ganesan, Sarina Piha-Paul, Aung Naing, et al.
Investigational New Drugs|September 13, 2013
OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma modelIlya Tsimafeyeu, Elina Zaveleva, Evgenia Stepanova, et al.
Investigational New Drugs|August 6, 2013
Reduced folate carrier (RFC) as a predictive marker for response to pemetrexed in advanced non-small cell lung cancer (NSCLC)Carlos Alvarez-Fernandez, Quionia Perez-Arnillas, Lucrecia Ruiz-Echeverria, et al.
Investigational New Drugs|August 27, 2013
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomasSeok Jin Kim, Hye Jin Kang, Jin Seok Kim, et al.
Pageof 372